Pressmeddelanden, rapporter och bolagsmeddelande för Dancann Pharma
Spotlight News
Nyhetsuppdatering från Dancann Pharma
Press release from Companies: Correction: DanCann Pharma A/S invites to an investor presentation and Q&A session in relation to ongoing exercise period of warrants
Spotlight News
Nyhetsuppdatering från Dancann Pharma
Press release from Companies: DanCann Pharma A/S invites to an investor presentation and Q&A session in relation to ongoing exercise period of warrants
Spotlight News
Nyhetsuppdatering från Dancann Pharma
Press release from Companies: DanCann Pharma A/S: The exercise period for warrants of series TO 2 begins today
Spotlight News
Nyhetsuppdatering från Dancann Pharma
Press release from Companies: DanCann Pharma A/S: The subscription price for warrants of series TO 2 has been set
Spotlight News
Nyhetsuppdatering från Dancann Pharma
Press release from Companies: DanCann Pharma A/S styrker sit regulatoriske fokus med indstilling af life science-advokat til bestyrelsen
Spotlight News
Nyhetsuppdatering från Dancann Pharma
Press release from Companies: DanCann Pharma A/S is strengthening its regulatory focus by appointing a life science lawyer to the board of directors
Spotlight News
Nyhetsuppdatering från Dancann Pharma
Press release from Companies: NOTICE OF ANNUAL GENERAL MEETING 2023 IN DANCANN PHARMA A/S
Spotlight News
Nyhetsuppdatering från Dancann Pharma
Press release from Companies: DanCann Pharma A/S publishes Annual Report 2022
Spotlight News
Nyhetsuppdatering från Dancann Pharma
Press release from Companies: DanCann Pharma A/S has signed an exclusive contract with MYCB1 GmbH for the distribution of full-spectrum extracts based on Bedrocan International varieties
Spotlight News
Nyhetsuppdatering från Dancann Pharma
Press release from Companies: DanCann Pharma A/S has signed an exclusive contract with MYCB1 GmbH for the distribution of full-spectrum extracts based on Bedrocan International varieties